Develops and provides molecular diagnostic solutions for infectious diseases
Mobidiag UK
Our goal: develop innovative molecular diagnostic solutions to advance the diagnosis of infectious diseases and antibiotic resistances.
Mobidiag is a commercial stage, fast-growing Finnish-French biotechnology company. At Mobidiag, we develop and market innovative molecular diagnostic solutions for Gastrointestinal Infections, Antimicrobial Resistance Management, Healthcare Associated Infections (HAIs), Respiratory Infections and Sepsis.
Based on well-established qPCR and microarray technologies, Mobidiag offers a broad range of tests and automated platforms. These include a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases adapted to laboratories of all sizes. They allow detection of most clinically relevant bacteria, parasites, viruses and antibiotic resistances.